Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks.
暂无分享,去创建一个
[1] M. Cavet,et al. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells , 1997, Antimicrobial agents and chemotherapy.
[2] Gilles Klopman,et al. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] E. Furfine,et al. Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir , 2004, Antimicrobial Agents and Chemotherapy.
[4] Ming Hu,et al. Mechanism of L-α-Methyldopa Transport Through a Monolayer of Polarized Human Intestinal Epithelial Cells (Caco-2) , 1990, Pharmaceutical Research.
[5] B B Brodie,et al. Mechanisms of drug absorption and of drug solution. , 1972, Pharmacology.
[6] Leo Abrahamse,et al. Comparison of in Vitro Models for the Prediction of Compound Absorption across the Human Intestinal Mucosa , 2004, Journal of biomolecular screening.
[7] Kiyohiko Sugano,et al. Correction of Permeability with Pore Radius of Tight Junctions in Caco-2 Monolayers Improves the Prediction of the Dose Fraction of Hydrophilic Drugs Absorbed by Humans , 2004, Pharmaceutical Research.
[8] Cheng-Pang Hsu,et al. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. , 2001, Journal of pharmacological and toxicological methods.
[9] Anders Karlén,et al. Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability. , 2003, Journal of molecular graphics & modelling.
[10] J. Pachot,et al. Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[11] H Lennernäs,et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.
[12] Li Di,et al. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. , 2004, Journal of pharmaceutical sciences.
[13] S. Stavchansky,et al. Link between drug absorption solubility and permeability measurements in Caco-2 cells. , 1998, Journal of pharmaceutical sciences.
[14] J. Dearden,et al. In Silico Prediction of Physicochemical Properties , 2007 .
[15] Paulo Paixão,et al. Prediction of drug distribution within blood. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[16] Igor V. Tetko,et al. Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..
[17] J R Chretien,et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. , 1998, Journal of drug targeting.
[18] P. Selzer,et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.
[19] G. Knipp,et al. Delineation of Human Peptide Transporter 1 (hPepT1)-Mediated Uptake and Transport of Substrates with Varying Transporter Affinities Utilizing Stably Transfected hPepT1/Madin-Darby Canine Kidney Clones and Caco-2 Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[20] S. So,et al. Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors. , 1992, Journal of medicinal chemistry.
[21] Anton J Hopfinger,et al. Combined 4D-fingerprint and clustering based membrane-interaction QSAR analyses for constructing consensus Caco-2 cell permeation virtual screens. , 2008, Journal of pharmaceutical sciences.
[22] Päivi Tammela,et al. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. , 2004, Archives of biochemistry and biophysics.
[23] Hiroshi Saitoh,et al. Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. , 2002, Biological & pharmaceutical bulletin.
[24] Risto Kostiainen,et al. N-in-One Permeability Studies of Heterogeneous Sets of Compounds Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.
[25] J. V. Turner,et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.
[26] Malik Magdon-Ismail,et al. No Free Lunch for Early Stopping , 1999, Neural Computation.
[27] Fatima Martel,et al. Uptake of Serotonin at the Apical and Basolateral Membranes of Human Intestinal Epithelial (Caco-2) Cells Occurs through the Neuronal Serotonin Transporter (SERT) , 2003, Journal of Pharmacology and Experimental Therapeutics.
[28] M. Hashida,et al. Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. , 2002, International journal of pharmaceutics.
[29] Andrew Crowe,et al. The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. , 2002, European journal of pharmacology.
[30] Christer Tannergren. Intestinal permeability and presystemic extraction of fexofenadine and R/S-verapamil. , 2004 .
[31] Fumiyoshi Yamashita,et al. The "Latent Membrane Permeability" Concept: QSPR Analysis of Inter/Intralaboratorically Variable Caco-2 Permeability , 2002, J. Chem. Inf. Comput. Sci..
[32] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[33] James E. Polli,et al. Human Drug Absorption Kinetics and Comparison to Caco-2 Monolayer Permeabilities , 2004, Pharmaceutical Research.
[34] L. Walker,et al. Transport of harman alkaloids across Caco-2 cell monolayers. , 2004, Chemical & pharmaceutical bulletin.
[35] Ann Tronde. Pulmonary Drug Absorption : In vitro and in vivo investigations of drug absorption across the lung barrier and its relation to drug physicochemical properties , 2002 .
[36] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[37] Y. Martin,et al. A bioavailability score. , 2005, Journal of medicinal chemistry.
[38] G L Amidon,et al. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. , 2000, Journal of pharmaceutical sciences.
[39] Kazuya Nakao,et al. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. , 2005, Bioorganic & medicinal chemistry.
[40] P. Avontuur,et al. Solubility parameter and oral absorption. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[41] Lutz Prechelt,et al. Automatic early stopping using cross validation: quantifying the criteria , 1998, Neural Networks.
[42] Thomas Kissel,et al. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[43] S. Ekins. In silico approaches to predicting drug metabolism, toxicology and beyond. , 2003, Biochemical Society transactions.
[44] Riccardo Leonardi,et al. Caco-2 cell permeability modelling: a neural network coupled genetic algorithm approach , 2007, J. Comput. Aided Mol. Des..
[45] Adam Ibrahim,et al. Application of hydrogen bonding calculations in property based drug design. , 2002, Drug discovery today.
[46] Ryo Shimizu,et al. QSAR application for the prediction of compound permeability with in silico descriptors in practical use , 2009, J. Comput. Aided Mol. Des..
[47] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[48] Shiew-Mei Huang,et al. Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption , 1996, Pharmaceutical Research.
[49] P. Artursson,et al. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[50] Z. Değim,et al. Prediction of Permeability Coefficients of Compounds Through Caco-2 Cell Monolayer Using Artificial Neural Network Analysis , 2005, Drug development and industrial pharmacy.
[51] Mitsuru Sugawara,et al. Absorption of Ester Prodrugs in Caco-2 and Rat Intestine Models , 2004, Antimicrobial Agents and Chemotherapy.
[52] M Rowland,et al. Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. , 2001, American journal of physiology. Cell physiology.
[53] S. Venkatesh,et al. Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.
[54] Kristina Luthman,et al. Theoretical Predictions of Drug Absorption in Drug Discovery and Development , 2002, Clinical pharmacokinetics.
[55] Leann Nguyen,et al. Is PAMPA a useful tool for discovery? , 2007, Journal of pharmaceutical sciences.
[56] J J Baldwin,et al. Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.
[57] J. J. Voss,et al. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco‐2 cell monolayer model , 2004, Journal of clinical pharmacy and therapeutics.
[58] Klaus-Robert Müller,et al. Asymptotic statistical theory of overtraining and cross-validation , 1997, IEEE Trans. Neural Networks.
[59] Ailan Guo,et al. Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2) , 2004, BMC medicine.
[60] Tingjun Hou,et al. ADME Evaluation in Drug Discovery. 5. Correlation of Caco-2 Permeation with Simple Molecular Properties , 2004, J. Chem. Inf. Model..
[61] Hideyuki Saito,et al. Transport Mechanisms of Nicotine across the Human Intestinal Epithelial Cell Line Caco-2 , 2002, Journal of Pharmacology and Experimental Therapeutics.
[62] Sean Ekins,et al. Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication , 2001, J. Chem. Inf. Comput. Sci..
[63] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[64] T. Tsuruo,et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.
[65] Per Artursson,et al. Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.
[66] Corwin Hansch,et al. Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption , 2007, J. Comput. Aided Mol. Des..
[67] Kevin Holme,et al. Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[68] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[69] J. Sutherland,et al. A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.
[70] Liang-Shang Gan,et al. Mechanism of Intestinal Absorption of Ranitidine and Ondansetron: Transport Across Caco-2 Cell Monolayers , 1993, Pharmaceutical Research.
[71] S. Chong,et al. Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds. , 2005, International journal of pharmaceutics.
[72] W. Rubas,et al. Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption , 2004, Pharmaceutical Research.
[73] Mats Kihlén,et al. A General Model for Prediction of Caco‐2 Cell Permeability , 2004 .
[74] Christoph Hiemke,et al. How Does the Benzamide Antipsychotic Amisulpride get into the Brain?—An In Vitro Approach Comparing Amisulpride with Clozapine , 2003, Neuropsychopharmacology.
[75] Donna A Volpe,et al. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. , 2008, Journal of pharmaceutical sciences.
[76] Francisco Torrens,et al. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. , 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[77] Shufeng Zhou,et al. Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[78] Marc Parham,et al. Prediction of aqueous solubility based on large datasets using several QSPR models utilizing topological structure representation. , 2004, Chemistry & biodiversity.
[79] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[80] U. Christians,et al. Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayers , 2000, British journal of pharmacology.
[81] I. Tetko,et al. Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. , 2004, Journal of pharmaceutical sciences.
[82] Guang-Ji Wang,et al. Transport and uptake characteristics of a new derivative of berberine (CPU-86017) by human intestinal epithelial cell line: Caco-2. , 2003, Acta pharmacologica Sinica.
[83] G Folkers,et al. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[84] A. Mitra,et al. Interactions of the Dipeptide Ester Prodrugs of Acyclovir with the Intestinal Oligopeptide Transporter: Competitive Inhibition of Glycylsarcosine Transport in Human Intestinal Cell Line-Caco-2 , 2003, Journal of Pharmacology and Experimental Therapeutics.
[85] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[86] Bart Willems,et al. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. , 2004, Journal of pharmaceutical sciences.
[87] Henrike Potthast,et al. Biopharmaceutical characterization of sotalol-containing oral immediate release drug products. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[88] David A Winkler,et al. Neural networks as robust tools in drug lead discovery and development , 2004, Molecular biotechnology.
[89] Kikuo Iwamoto,et al. Transepithelial permeation of tolbutamide across the human intestinal cell line, Caco-2. , 2004, Drug metabolism and pharmacokinetics.
[90] Istvan Toth,et al. Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[91] D. Butina,et al. Performance of Kier-Hall E-state descriptors in quantitative structure activity relationship (QSAR) studies of multifunctional molecules. , 2004, Molecules.
[92] Maria Guangli,et al. Predicting Caco-2 permeability using support vector machine and chemistry development kit. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[93] G. Caldwell,et al. In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. , 1998, Journal of mass spectrometry : JMS.
[94] H Lennernäs,et al. Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. , 1999, Acta physiologica Scandinavica.
[95] Philippe Arnaud,et al. Short term Caco-2/TC7 cell culture: comparison between conventional 21-d and a commercially available 3-d system. , 2004, Biological & pharmaceutical bulletin.
[96] Denis M. Bayada,et al. Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.
[97] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[98] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[99] Francisco Torrens,et al. Estimation of ADME properties in drug discovery: predicting Caco-2 cell permeability using atom-based stochastic and non-stochastic linear indices. , 2007, Journal of pharmaceutical sciences.
[100] Ning Li,et al. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management. , 2003, World journal of gastroenterology.
[101] Andrew Crowe,et al. In Vitro and In Situ Absorption of SDZ-RAD Using a Human Intestinal Cell Line (Caco-2) and a Single Pass Perfusion Model in Rats: Comparison with Rapamycin , 1998, Pharmaceutical Research.
[102] Gordon L. Amidon,et al. Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.
[103] J. Finley,et al. The Influence of Culture Time and Passage Number on the Morphological and Physiological Development of Caco-2 Cells , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[104] Ismael Zamora,et al. pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions , 2003, Pharmaceutical Research.
[105] Fumiyoshi Yamashita,et al. Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial least squares method. , 2002, Journal of pharmaceutical sciences.
[106] Kazuya Nakao,et al. QSAR study on permeability of hydrophobic compounds with artificial membranes. , 2007, Bioorganic & medicinal chemistry.
[107] Kristina Luthman,et al. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.
[108] Marjo Yliperttula,et al. Computational prediction of oral drug absorption based on absorption rate constants in humans. , 2006, Journal of medicinal chemistry.
[109] Igor V. Tetko,et al. Neural Network Studies, 2. Variable Selection , 1996, J. Chem. Inf. Comput. Sci..
[110] Tingjun Hou,et al. ADME evaluation in drug discovery , 2002, Journal of molecular modeling.
[111] Thomas Walle,et al. Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2 , 2003, Journal of Pharmacology and Experimental Therapeutics.
[112] Gregg D. Wilensky,et al. Neural Network Studies , 1993 .
[113] P. Gramatica,et al. Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors. , 2000, Chemosphere.
[114] Araz A. Raoof,et al. In Vivo Assessment of Intestinal, Hepatic, and Pulmonary First Pass Metabolism of Propofol in the Rat , 1996, Pharmaceutical Research.
[115] U Norinder,et al. Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. , 2001, Journal of pharmaceutical sciences.